I am currently working on my master’s thesis, which is the second part of a series. In my thesis part 1, titled ‘Adverse Drug Event Detection Using NLP Techniques’, I attempted to reproduce the results of a paper but had to adapt the methodology to a different dataset (n2c2) due to data availability constraints. My focus was on Named Entity Recognition (NER) for identifying Adverse Drug Events (ADE) in clinical text, where I fine-tuned a DeBERTa model.